Mumbai: IOL Chemicals & Pharmaceuticals Ltd said on Wednesday it will invest Rs 75 crore to manufacture anti-ulcer drug rabiprazole.
Thursday, March 13, 2008
Subscribe to:
Post Comments (Atom)
|
By clicking on this blog you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions and we request them to study all aspects before taking decisions.
No comments:
Post a Comment